OOIR: Observatory of International Research

Papers

(The median citation count of Health Economics Policy and Law is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Australia's Response to COVID-19	79
Response to COVID-19: was Italy (un)prepared?	44
France's response to the Covid-19 pandemic: between a rock and a hard place	29
United States response to the COVID-19 pandemic, January–November 2020	24
Unmasking a health care system: the Dutch policy response to the Covid-19 crisis	21
Need, demand, supply in health care: working definitions, and their implications for defining access	21
Going hard and early: Aotearoa New Zealand's response to Covid-19	18
The federal government and Canada's COVID-19 responses: from ‘we're ready, we're prepared’ to ‘fires are burning’	11
Ireland's takeover of private hospitals during the COVID-19 pandemic	11
Soft law and individual responsibility: a review of the Swedish policy response to COVID-19	11
Changes in the balance between formal and informal care supply in England between 2001 and 2011: evidence from census data	10
Health economics and emergence from COVID-19 lockdown: the great big marginal analysis	10
Neither protective nor harmonized: the crossborder regulation of medical devices in the EU	10
Alternative provision of public health care: the role of citizens' satisfaction with public services and the social responsibility of government	9
Evolution of the determinants of unmet health care needs in a universal health care system: Canada, 2001–2014	9
Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride?	9
Health, federalism and the European Union: lessons from comparative federalism about the European Union	7
Belgium's response to the COVID-19 pandemic	7
World-beating? Testing Britain's Covid response and tracing the explanation	7
Understanding public procurement within the health sector: a priority in a post-COVID-19 world	7
Past experiences with surprise medical bills drive issue knowledge, concern and attitudes toward federal policy intervention	7
Necessity under construction – societal weighing rationality in the appraisal of health care technologies	7
Any lessons to learn? Pathways and impasses towards health system resilience in post-pandemic times	7
State strategies to address medicaid prescription spending: negotiated pricing vs price transparency	6
A tribute to the foot soldiers: European health agencies in the fight against antimicrobial resistance	6

Resilient managed competition during pandemics: lessons from the Italian experience during COVID-19	6
Expanding health care coverage in Canada: a dramatic shift in the debate	6
Do patients benefit from legislation regulating step therapy?	6
An application of PCA-DEA with the double-bootstrap approach to estimate the technical efficiency of New Zealand District Health Boards	6
Assessing the potential impact on health of the UK's future relationship agreement with the EU: analysis of the negotiating positions	5
Learning from health system reform trajectories in seven Canadian provinces	5
Strengthening health system governance in Germany: looking back, planning ahead	5
Learning lessons from the COVID-19 pandemic	4
Internal barriers to efficiency: why disinvestments are so difficult. Identifying and addressing internal barriers to disinvestment of health technologies	4
Physician behaviour, malpractice risk and defensive medicine: an investigation of cesarean deliveries	4
Preserving social equity in marketized primary care: strategies in Sweden	4
(Re)defining legitimacy in Canadian drug assessment policy? Comparing ideas over time	4
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment	3
Why we need to face up to the ageing population?	3
Resilient managed competition during pandemics: lessons from the Italian experience	3
Mandatory reporting legislation in Canada: improving systems for patient safety?	3
Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals	3
Exorcising the positivist ghost in the priority-setting machine: NICE and the demise of the ‘social value judgement’	3
Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?	2
Challenges to sovereign ambitions: forces of convergence and divergence within the global pharmaceutical sector and the UK's withdrawal from the European Union	2
Impact on the NHS and health of the UK's trade and cooperation relationship with the EU, and beyond	2
Can Asia provide models for tax-based European health systems? A comparative study of Singapore and Sweden	2
‘Nurses are seen as general cargo, not the smart TVs you ship carefully’: the politics of nurse staffing in England, Spain, Sweden, and the Netherlands	2
The effects of a sugar-sweetened beverage tax: moving beyond dental health outcomes and service utilisation	2
EU mental health governance and citizen participation: a global governmentality perspective	2
Conceptualising equity in the impact evaluation of chronic disease management programmes: a capabilities approach	2
Observations from a small country: mental health policy, services and nursing in Wales	2
If you were a policymaker, which treatment would you disinvest? A participatory value evaluation on public preferences for active disinvestment of health care interventions in the Netherlands	2
Accelerating integration of social needs into mainstream healthcare to achieve health equity in the COVID-19 era	2
Effects of public long-term care insurance on the medical service use by older people in South Korea	2
Just a question of time? Explaining non-take-up of a public health insurance program designed for undocumented immigrants living in France	2
Trump v. The ACA	2
EU health law and policy: shaping a future research agenda	2
Answers in search of questions: what does the comparison of COVID19 data among regions in Northern Italy tell us?	2
Reinterpreting the health in all policies obligation in Article 168 TFEU: the first step towards making enforcement a realistic prospect	2
Health care reform and financial crisis in the Netherlands: consequences for the financial arena of health care organizations	1
Public health by organizational fix?	1
The constitutional economics of the World Health Organization	1
The normative grounds for NICE decision-making: a narrative cross-disciplinary review of empirical studies	1
How to fairly allocate scarce medical resources? Controversial preferences of healthcare professionals with different personal characteristics	1
Coping with COVID-19: the role of hospital care structures and capacity expansion in five countries	1
Explaining system-level change in welfare governance: the role of policy indeterminacy and concatenations of social mechanisms	1
Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit	1
Strengthening primary health care in China: governance and policy challenges	1
The role of EU competition law in health care and the ‘undertaking’ concept	1
Privatising, liberalising and dividing a welfare state without affecting universality? Debunking the myths surrounding the rapid rise of private health insurance in Sweden	1
Exploring differences between public and private providers in primary care: findings from a large Swedish region	1
Is the emergency department used as a substitute or a complement to primary care in Medicaid?	1
Does voluntary health insurance reduce the use of and the willingness to finance public health care in Sweden?	1
Structuring complexity? A systemic perspective on the implementation of a disease management programme for type II diabetes care in Denmark	1

Towards more comprehensive health law and policy research	1
New governance of the digital health agency: a way out of the joint decision trap to implement electronic health records in Germany?	1
Explaining health system responses to public reporting of cardiac surgery mortality in England and the USA	1
Tort reform: do details matter?	1